Terms: = Kidney tumors AND LCK, YT16, 3932, P06239, ENSG00000182866, p56lck, pp58lck
13 results:
1. Association of Genetic Ancestry and Molecular Signatures with Cancer Survival Disparities: A Pan-Cancer Analysis.
Lee KK; Rishishwar L; Ban D; Nagar SD; Mariño-Ramírez L; McDonald JF; Jordan IK
Cancer Res; 2022 Apr; 82(7):1222-1233. PubMed ID: 35064017
[TBL] [Abstract] [Full Text] [Related]
2. Identification of biomarkers related to CD8
Lin J; Yu M; Xu X; Wang Y; Xing H; An J; Yang J; Tang C; Sun D; Zhu Y
Aging (Albany NY); 2020 Feb; 12(4):3694-3712. PubMed ID: 32081834
[TBL] [Abstract] [Full Text] [Related]
3. Identifying hub genes of clear cell renal cell carcinoma associated with the proportion of regulatory T cells by weighted gene co-expression network analysis.
Chen YH; Chen SH; Hou J; Ke ZB; Wu YP; Lin TT; Wei Y; Xue XY; Zheng QS; Huang JB; Xu N
Aging (Albany NY); 2019 Oct; 11(21):9478-9491. PubMed ID: 31672930
[TBL] [Abstract] [Full Text] [Related]
4. Expression and prognostic significance of Src family members in renal clear cell carcinoma.
Qayyum T; McArdle PA; Lamb GW; Jordan F; Orange C; Seywright M; Horgan PG; Jones RJ; Oades G; Aitchison MA; Edwards J
Br J Cancer; 2012 Aug; 107(5):856-63. PubMed ID: 22814579
[TBL] [Abstract] [Full Text] [Related]
5. Immunosuppression in renal cancer: differential expression of signal transduction molecules in tumor-infiltrating, near-tumor tissue, and peripheral blood lymphocytes.
Riccobon A; Gunelli R; Ridolfi R; De Paola F; Flamini E; Fiori M; Saltutti C; Petrini M; Fiammenghi L; Stefanelli M; Granato AM; Cuzzocrea DE; Amadori D
Cancer Invest; 2004; 22(6):871-7. PubMed ID: 15641485
[TBL] [Abstract] [Full Text] [Related]
6. Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies.
Meco D; Colombo T; Ubezio P; Zucchetti M; Zaffaroni M; Riccardi A; Faircloth G; Jose J; D'Incalci M; Riccardi R
Cancer Chemother Pharmacol; 2003 Aug; 52(2):131-8. PubMed ID: 12783202
[TBL] [Abstract] [Full Text] [Related]
7. [Molecular portrait of human kidney carcinomas: the gene expression profiling of protein-tyrosine kinases and tyrosine phosphatases which controlled regulatory signals in the cells].
Cheburkin IuV; Kniazeva TG; Peter S; Kniazev IuP; Karelin MI; Shkol'nik MI; Evtushenko VI; Hanson KP; Ullrich A; Kniazev PG
Mol Biol (Mosk); 2002; 36(3):480-90. PubMed ID: 12068634
[TBL] [Abstract] [Full Text] [Related]
8. Restoration of expression of signal-transduction molecules in lymphocytes from patients with metastatic renal cell cancer after combination immunotherapy.
Gratama JW; Zea AH; Bolhuis RL; Ochoa AC
Cancer Immunol Immunother; 1999 Aug; 48(5):263-9. PubMed ID: 10478643
[TBL] [Abstract] [Full Text] [Related]
9. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.
Bukowski RM; Rayman P; Uzzo R; Bloom T; Sandstrom K; Peereboom D; Olencki T; Budd GT; McLain D; Elson P; Novick A; Finke JH
Clin Cancer Res; 1998 Oct; 4(10):2337-47. PubMed ID: 9796963
[TBL] [Abstract] [Full Text] [Related]
10. Adjuvant adoptive immunotherapy with tumour-infiltrating lymphocytes and modulated doses of interleukin-2 in 22 patients with melanoma, colorectal and renal cancer, after radical metastasectomy, and in 12 advanced patients.
Ridolfi R; Flamini E; Riccobon A; De Paola F; Maltoni R; Gardini A; Ridolfi L; Medri L; Poletti G; Amadori D
Cancer Immunol Immunother; 1998 Jun; 46(4):185-93. PubMed ID: 9671141
[TBL] [Abstract] [Full Text] [Related]
11. Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas.
Kolenko V; Wang Q; Riedy MC; O'Shea J; Ritz J; Cathcart MK; Rayman P; Tubbs R; Edinger M; Novick A; Bukowski R; Finke J
J Immunol; 1997 Sep; 159(6):3057-67. PubMed ID: 9300731
[TBL] [Abstract] [Full Text] [Related]
12. Phase II trial of interleukin-2 and interferon-alpha in patients with renal cell carcinoma: clinical results and immunologic correlates of response.
Bukowski RM; Olencki T; Wang Q; Peereboom D; Budd GT; Elson P; Sandstrom K; Tuason L; Rayman P; Tubbs R; McLain D; Klein E; Novick A; Finke J
J Immunother; 1997 Jul; 20(4):301-11. PubMed ID: 9220320
[TBL] [Abstract] [Full Text] [Related]
13. Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma.
Finke JH; Zea AH; Stanley J; Longo DL; Mizoguchi H; Tubbs RR; Wiltrout RH; O'Shea JJ; Kudoh S; Klein E
Cancer Res; 1993 Dec; 53(23):5613-6. PubMed ID: 8242613
[TBL] [Abstract] [Full Text] [Related]
